Indranil Dey
President and CEO at Bluejay Diagnostics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Bluejay Diagnostics Inc., 3 years.
Bluejay Diagnostics Inc.
Director · President and CEO
Chief executive roles
Bluejay Diagnostics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Bluejay Diagnostics Inc. | Grant or award | +28,000 | — | — |
| Mar 14, 2026 | Bluejay Diagnostics Inc. | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Dec 13, 2023 | Bluejay Diagnostics Inc. | Open-market purchase | +500 | $3.27 | $1,635 |
| Mar 28, 2023 | Bluejay Diagnostics Inc. | Grant or award | +2,000 | $0.44 | $880 |
| Mar 27, 2023 | Bluejay Diagnostics Inc. | Grant or award | +8,000 | $0.44 | $3,520 |
| Feb 1, 2023 | Bluejay Diagnostics Inc. | Grant or award | +159,090 | $0.44 | $70,000 |
| Feb 1, 2023 | Bluejay Diagnostics Inc. | Shares withheld for tax | −55,612 | $0.44 | $24,469 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.